(Q37946264)

25 August 2017

title

Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights (English)

1 reference

25 August 2017

1 reference

Kimberly Ng

1

1 reference

25 August 2017

Ryan Kim

2

1 reference

25 August 2017

Santosh Kesari

3

1 reference

25 August 2017

Bob Carter

4

1 reference

25 August 2017

Clark C Chen

5

1 reference

25 August 2017

publication date

16 October 2011

1 reference

Journal of Neuro-Oncology

25 August 2017

published in

1 reference

25 August 2017

volume

107

1 reference

25 August 2017

issue

1

1 reference

25 August 2017

page(s)

1-12

1 reference

https://scigraph.springernature.com/pub.10.1007/s11060-011-0714-2

25 August 2017

exact match

0 references

cites work

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Proto-oncogenes in cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

An integrated genomic analysis of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Malignant gliomas in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Molecular subclassification of diffuse gliomas: seeing order in the chaos

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Cell signaling by receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Exploiting the PI3K/AKT pathway for cancer drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

The phosphoinositide 3-kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

A human brain tumor-derived PDGFR-alpha deletion mutant is transforming

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Identification of IGF2 signaling through phosphoinositide-3-kinase regulatory subunit 3 as a growth-promoting axis in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Targeting RAS signalling pathways in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

A prospective study of neurofibromatosis type 1 cancer incidence in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Targeting the RB-pathway in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

The retinoblastoma protein is phosphorylated during specific phases of the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Genome-wide association study identifies five susceptibility loci for glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Caspase family proteases and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Intrinsic tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Apoptosis control by death and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Apoptosis - the p53 network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Concurrent inactivation of RB1 and TP53 pathways in anaplastic oligodendrogliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Gliomagenesis: genetic alterations and mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Telomere shortening and apoptosis in telomerase-inhibited human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Protein composition of catalytically active human telomerase from immortal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

VEGFs, receptors and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

HIF1 and oxygen sensing in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

IDH1 and IDH2 mutations in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Mutant metabolic enzymes are at the origin of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

The 2007 WHO classification of tumours of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Recurring mutations found by sequencing an acute myeloid leukemia genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Histone demethylation by a family of JmjC domain-containing proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Involvement of RB gene family in tumor angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Vascular endothelial growth factor and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Control of astrocyte migration in the developing cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Reactive astrocytes: cellular and molecular cues to biological function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Mutant p53 drives invasion by promoting integrin recycling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

The epidermal growth factor receptor in malignant gliomas: pathogenesis and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

The RB and p53 pathways in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Genetic alterations during colorectal-tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

The pathobiology of glioma tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Mutational heterogeneity in human cancers: origin and consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

A developmental taxonomy of glioblastoma defined and maintained by MicroRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

The transcriptional network for mesenchymal transformation of brain tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Cancer genome sequencing--an interim analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0714-2

The retinoblastoma gene is involved in malignant progression of astrocytomas

21 January 2018

1 reference

12 December 2020

Molecular classification of human diffuse gliomas by multidimensional scaling analysis of gene expression profiles parallels morphology-based classification, correlates with survival, and reveals clinically-relevant novel glioma subsets

1 reference

12 December 2020

Oncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts

1 reference

12 December 2020

Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes.

1 reference

12 December 2020

Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques.

1 reference

12 December 2020

Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma.

1 reference

12 December 2020

Molecular principles of cancer invasion and metastasis (review).

1 reference

12 December 2020

Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.

1 reference

12 December 2020

Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA.

1 reference

12 December 2020

p53 tumor suppressor gene: from the basic research laboratory to the clinic--an abridged historical perspective

1 reference

12 December 2020

10.1007/S11060-011-0714-2

Identifiers

DOI

1 reference

25 August 2017

1 reference